Smith+Nephew has launched the next generation LEAF Patient Monitoring System in the US, a pressure injury prevention platform designed to reduce hospital-acquired pressure injuries (HAPIs). The cloud-hosted system uses wearable sensors to monitor patient mobility and provide real-time turn status updates, improving workflow efficiency and protocol adherence. HAPIs cause approximately 60,000 annual deaths in the US and cost the economy $26.8 billion yearly. The LEAF system has demonstrated a 73% reduction in HAPI odds compared to standard care and delivers up to $1.8 million in estimated savings per critical care facility. The enhanced platform features an improved user interface developed with nursing teams and integrates seamlessly with hospital electronic medical records. It currently monitors over 150,000 patients annually across healthcare facilities.

Bernstein has cut its price target on Smith & Nephew to $31.85 from $36.20, maintaining a Market Perform rating. The adjustment followed the medical device company's fiscal Q1 trading update, which showed organic sales growth of 3.1%, missing the consensus estimate of 3.8%. Canaccord also reduced its price target to $30 from $32 the same day, keeping a Hold rating. Smith & Nephew reported Q1 revenue of $1.5 billion, with underlying revenue growth of 3.1% and reported growth of 6.6%, including a 350 basis point foreign exchange tailwind. The company develops and sells medical devices across three segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management.

Smith+Nephew is launching two chronic wound care products at the European Wound Management Association Conference in Bremen from 6–8 May 2026. The innovations address a challenge affecting up to 14.9 million people in Europe and consuming up to 4% of healthcare spending. ALLEVYN COMPLETE CARE Foam Dressing features a five-layer construction with Enhanced ExuLOCK Technology that locks in exudate and bacteria, releasing up to 100 times fewer bacteria than other foam dressings. The product includes an ExuMASK Change Indicator for longer wear times and ShearDEFENSE technology to protect against pressure injuries. RENASYS EDGE Negative Pressure Wound Therapy System offers a lightweight, portable pump with modular design that eliminates annual servicing requirements. The system achieved 88% patient compliance and improved wound outcomes.